Cookies: Information & Consent

We have placed cookies on your device to help make this website better. Some of the cookies we use are essential for this site to work. We also use some non-essential cookies to collect information for making reports and to help us improve the site. You will find more detailled information in our Privacy Chart.

March 2020

Banook Group welcomes Turenne Santé as new investor, alongside the management

Funds obtained will enable the European leader in cardiac safety to continue its…
Read the full post
May 2018

Webinar : Advances in cardiovascular diagnostic devices for clinical trial

Tuesday, May 29th, 2018  6:00 PM CEST (Central European Time) UTC/GMT + 2…
Read the full post
April 2017

Event Participation 2017

Banook Group will attend the following exhibitions. Let’s meet there!
Read the full post
February 2017

Cardiabase by Banook Group opens subsidiary in Montreal, Canada

Group strengthens its presence in North American market, aiming for 30% growth in…
Read the full post
March 2015

Banook Group - New branding announcement

Cardiabase/Banook Central Imaging becomes Banook Group - New branding announcement.
Read the full post
March 2014

Webinar: Imaging anti-cancer treatment response at a preclinical and clinical stage

Use of imaging in oncology clinical trials is mainly based on morphological evaluation…
Read the full post
Mission & strategy > Our governance > Management

Our governance

For each level of our governance, the key words are strong experience and motivation to further research and knowledge.

Scientific board

Dr. Pascal Voiriot


Dr. Pascal Voiriot received his MD from Nancy University, France in 1980 where he specialized in internal medicine (infectious diseases) and cardiology. Dr. Voiriot has been involved in drug evaluations since 1989 as a consultant for the French National Agency of Medicine and Health Products Safety (ANSM) for the cardiology, anti-infective agents and clinical trials fields.

In 1999 he founded Cardiabase, a cardiac safety and efficacy core lab based in France. Since 1985, he has been involved in more than 150 scientific presentations and publications covering internal medicine and cardiology topics.

Alexandre Durand-Salmon


Alexandre Durand-Salmon joined Banook Medical Services Group in 2010 and brings over 15 years of experience in the eClinical arena as Co-founder and Director of Operations for KIKA Medical, an EDC company created in 1997 and acquired by Merge Healthcare in 2010. Mr. Durand-Salmon successfully blends the techno­logically advanced medical imaging programming and software with the medical and scientific needs of the clinical trial world.

Yasmin Khan


Strong of multidisciplinary background in Bioinformatics, Yasmin Khan has joined Cardiabase-BanookGroup in 2003. Involved since the very first times in the company she has taken lead of Operations in Cardiac Safety for clinical trials. In charge of team of study managers she is committed to process improvement by reaching efficiency and reliability. Regulatory compliance and Sponsor satisfaction being her priority she has been involved for projects to the CSRC and WHO to share of expertise gained by the company over the years.

Stéphane Papelier


Stéphane Papelier

Dr. Pierre Wicker


Dr. Wicker is a Board-Certified Cardiologist who received his MD from the University of Bordeaux, France. In 1984 he began his career with the Cleveland Clinic Foundation before joining the pharmaceutical industry in 1989. With more than 20 years of drug development experience with major international pharmaceutical companies, Dr. Wicker contributes his expertise and knowledge to help Sponsors design the most time and cost efficient cardiovascular safety assessment program.

While at Pfizer, Dr. Wicker managed several development programs from early discovery to phase III, predominately in the cardiovascular area. Over the past decade, he has acquired a unique expertise in cardiovascular safety and QT assessment, first as a member and then as co-chair of the Pfizer Cardiovascular Safety Council.

Dr. Gérard Nitenberg

CMO – Imaging

Dr. Gerard Nitenberg is the Former Medical Director and Quality Manager at Institut Gustave Roussy (IGR) Paris XI University – France.

Gerard Nitenberg spent the majority of his medical career at the Institut Gustave Roussy, where he served successively as the Head of the departments of anesthesia, intensive care and infectious diseases, as well as holding positions as Quality Manager and Medical Director. The Institut Gustave Roussy is recognized globally as Europe’s leading cancer research and treatment center, involved in major programs of basic and clinical research in cancer.

Dr. Nitenberg served as Assistant General Manager at IGR for over 15 years and was responsible for the overall development of supportive care in cancer patients and introduced the specific concept of critical care in immunocompromized patients in France. He is the author or co-author of over 200 scientific articles, books, and videos. Dr. Nitenberg has lectured extensively, both nationally and internationally, and was a visiting scientist and professor at the University of California-San Francisco.